Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol MYSM1 contributors: mct - updated : 25-03-2015
HGNC name myb-like, SWIRM and MPN domains 1
HGNC id 29401
Corresponding disease
BMFS4 bone marrow failure syndrome 4
Location 1p32.1      Physical location : 59.125.589 - 59.165.747
Synonym symbol(s) DKFZp779J1554, DKFZp779J1721, KIAA1915, 2ADUB, 2A-DUB, BMFS4
EC.number 3.1.2.15
DNA
TYPE functioning gene
STRUCTURE 45.34 kb     14 Exon(s)
MAPPING cloned Y linked N status provisional
RNA
TRANSCRIPTS type messenger
identificationnb exonstypebpproduct
ProteinkDaAAspecific expressionYearPubmed
20 - 7768 - 828 - 2007 17707232
EXPRESSION
Type
   expressed in (based on citations)
organ(s)
SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
Lymphoid/Immunethymus    
Reproductivemale systemprostate   
tissue
SystemTissueTissue level 1Tissue level 2LevelPubmedSpeciesStageRna symbol
Blood / hematopoieticbone marrow   
Muscular    
Nervousperipherous   
cell lineage
cell lines
fluid/secretion blood
at STAGE
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
one Myb-like domain
conjugated MetalloP
HOMOLOGY
Homologene
FAMILY
CATEGORY regulatory
SUBCELLULAR LOCALIZATION     intracellular
intracellular,cytoplasm,cytosolic
intracellular,nucleus,nucleoplasm
intracellular,nucleus,nucleolus
text
  • normally localizes to the nucleus, where it can interact with chromatin and regulate gene expression, through deubiquitination of histone H2A and non-catalytic contacts with other transcriptional regulators
  • basic FUNCTION
  • essential role for MYSM1 in gene transcription during early B cell development
  • critical role of histone H2A-deubiquitinase MYSM1 in hematopoiesis and lymphocyte differentiation
  • histone H2A deubiquitinase, with important role for NK cell maturation
  • required for NK cell maturation but not for NK lineage specification and commitment
  • MYSM1 functions potentially downstream of IL15 during NK cell development
  • its activity in promoting the transcription of ID2 is essential for the development of mature NK cells (
  • has an important and intrinsic role in NK cell development through an epigenetic control of ID2 transcription, which is critical for NK cell development
  • is essential for proper immunohematopoietic development
  • is an epigenetic regulator essential for the maintenance of hematopoietic stem cell (HSC) function, hematopoietic progenitor survival, and lymphocyte development
  • is a chromatin-binding histone deubiquitinase
  • has an essential role in B cell lineage specification but is dispensable at later stages of development
  • important role of MYSM1 in maintaining HSC quiescence and survival
  • MYSM1 is essential for macrophage survival and plays an important role in macrophage polarization
  • is a transcriptional regulator essential for hematopoietic stem cells (HSCs) function and hematopoiesis
  • critical role of MYSM1 DUB catalytic activity in hematopoiesis, leukocyte development, and other aspects of mammalian physiology
  • CELLULAR PROCESS nucleotide, transcription, regulation
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism
    signaling
    a component
    INTERACTION
    DNA binding
    RNA
    small molecule
    protein
  • directly associates with the GFI1 enhancer element and promotes its transcription through GATA2 and RUNX1 transactivation
  • plays a critical role in early B-cell commitment and development by de-repressing the transcription of EBF1
  • MYSM1 protein is associated with the ID2 locus
  • MYSM1 and its interaction with NFIL3 are critical for the stable association of NFIL3 at the ID2 locus during NK cell development
  • is a critical negative regulator of TP53 transcriptional programs in hematopoiesis, and its repression of BBC3/PUMA expression is essential for multipotent progenitor (MPP) survival, and partly contributes to maintaining HSC function
  • cell & other
    REGULATION
    ASSOCIATED DISORDERS
    corresponding disease(s) BMFS4
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    constitutional germinal mutation      
    in a family with transient transfusion-dependent anemia, mild thrombocytopenia, and low NK- and B-cell counts
    Susceptibility
    Variant & Polymorphism
    Candidate gene
    Marker
    Therapy target
    SystemTypeDisorderPubmed
    osteoarticularboneostéoporosis
    may represent a potential therapeutic target for controlling MSC lineage differentiation, and possibly for the treatment of metabolic bone diseases such as osteoporosis
    ANIMAL & CELL MODELS
  • blockage in the maturation of NK cells during NK cell development in Mysm1-/- mice
  • Mysm1-/- mice had a lower bone mass both in long bone and calvaria compared with their control counterpart